Chart: Medical marijuana markets expanding at varying rates, with Oklahoma, Florida setting the pace


2019-08-15 10:35:00 mjbizdaily


While medical marijuana is legally available in 36 states and Washington DC, the fragmented nature of the industry – each state creates its own set of rules – means each market grows at a different rate. An analysis of state markets that release patient counts on at least a quarterly basis reveals several key takeaways: Oklahoma is the fastest-growing medical marijuana market in the average number of daily patient increases, and MMJ patients represent 4.1% of the state’s total population – one of the highest rates in the nation. Growth is bolstered by low barriers of entry, including the fact there’s no list of qualifying conditions for patients. Florida is the second-fastest-growing market in terms of patients joining the registry, with registered patients making up 1.6% of the state’s total population. This leaves room for further growth, which may occur from the recent legalization of smokable flower and continued wide access to dispensaries. Despite having operational markets for only a few months, Arkansas and Ohio have reached a statewide proportion of medical marijuana patients on par with mature markets such as Illinois, New Jersey and New York. After a strong first year of sales, Maryland’s medical marijuana program continues to grow, and regulators are evaluating a second round of business license applications for 10 processors and four cultivators to meet demand. Arizona and New Mexico continue to post solid growth and may benefit from recent developments in each state. New Mexico regulators expanded the state’s list of qualifying conditions for patients, are increasing the number of plants allowed to be grown by the state’s 35 vertically integrated operators and may be forced to allow for out-of-state reciprocity. Arizona regulators extended the life of medical marijuana cards from one year to two, and the state Supreme Court recently ruled that marijuana extracts are legal, ending nearly a year of confusion over the legality of sales of edibles, concentrates and other infused products.
虽然医用大麻在36个州和华盛顿特区都是合法的,但这个行业的支离破碎性质——每个州都制定自己的一套规则——意味着每个市场的增长速度不同。 对至少每季度发布一次病人数量统计数据的州市场的分析揭示了几个关键因素: 俄克拉荷马州是医用大麻市场增长最快的地区,每天平均病人数量增加,MMJ病人占该州总人口的4.1%,是全国比例最高的地区之一。低准入门槛促进了增长,包括没有符合条件的患者名单。 佛罗里达州是登记在册的病人人数增长第二快的市场,登记在册的病人占该州总人口的1.6%。这为进一步的增长留下了空间,这可能发生在最近无烟花卉合法化和继续广泛进入药房。 尽管只有几个月的运营市场,阿肯色州和俄亥俄州的医用大麻患者比例已达到全州水平,与伊利诺斯州、新泽西州和纽约州等成熟市场相当。 马里兰州医用大麻项目在销售强劲的第一年之后继续增长,监管机构正在评估针对10家加工商和4家种植商的第二轮营业执照申请,以满足需求。 亚利桑那州和新墨西哥州的经济继续稳步增长,并可能从这两个州最近的发展中获益。新墨西哥州的监管机构扩大了该州患者的合格条件清单,增加了该州35家垂直整合运营商允许种植的植物的数量,并可能被迫允许州外互惠。亚利桑那州监管机构将医用大麻卡的有效期从一年延长至两年,该州最高法院最近裁定,大麻抽提物是合法的,从而结束了近一年以来人们对出售可食用食品、浓缩物和其他注射产品合法性的困惑。